INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,574,334 | -11.1% | 49,789 | +14.7% | 0.00% | 0.0% |
Q2 2023 | $1,769,944 | +54.3% | 43,402 | +41.0% | 0.00% | 0.0% |
Q1 2023 | $1,147,364 | +8.3% | 30,785 | +1.4% | 0.00% | 0.0% |
Q4 2022 | $1,059,093 | -25.2% | 30,355 | +20.1% | 0.00% | 0.0% |
Q3 2022 | $1,415,000 | +12.7% | 25,285 | +4.2% | 0.00% | 0.0% |
Q2 2022 | $1,256,000 | -4.8% | 24,257 | +33.5% | 0.00% | 0.0% |
Q1 2022 | $1,320,000 | -43.5% | 18,169 | -8.1% | 0.00% | -33.3% |
Q4 2021 | $2,338,000 | -13.4% | 19,774 | -1.7% | 0.00% | -25.0% |
Q3 2021 | $2,700,000 | -28.5% | 20,123 | -13.8% | 0.00% | -33.3% |
Q2 2021 | $3,778,000 | +65.0% | 23,336 | -18.2% | 0.01% | +50.0% |
Q1 2021 | $2,290,000 | +133.2% | 28,537 | +58.0% | 0.00% | +100.0% |
Q4 2020 | $982,000 | +319.7% | 18,060 | +122.3% | 0.00% | +100.0% |
Q3 2018 | $234,000 | – | 8,125 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |